Intelligent Product Solutions Names Jan Niewiadomski to CTO
HAUPPAUGE, N.Y., Jan. 30, 2024 (GLOBE NEWSWIRE) — Intelligent Product Solutions (IPS), an award-winning global product design firm, today announced […]
Nextech3D.ai Signs New 3D Modeling Contract with Enterprise Giant Global Industrial Company
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — via IBN — Nextech3D.AI (OTCQX: NEXCF) (CSE: NTAR) (FSE: 1SS), a Generative AI-Powered […]
Verizon Named Exclusive Wireless Telecommunications Provider of Tennessee Titans New Nissan Stadium
NASHVILLE, Tenn., Jan. 30, 2024 (GLOBE NEWSWIRE) — The Tennessee Titans today announced Verizon will be the exclusive wireless telecommunications […]
New Cradlepoint AI Functionality Advances 5G for Business
BOISE, Idaho, Jan. 30, 2024 (GLOBE NEWSWIRE) — Cradlepoint, the global leader in cloud-delivered LTE and 5G wireless network edge […]
First Financial Corporation Reports 2023 Results
TERRE HAUTE, Ind., Jan. 30, 2024 (GLOBE NEWSWIRE) — First Financial Corporation (NASDAQ:THFF) today announced results for the fourth quarter […]
Janover Named 2024 Commercial Real Estate Tech Influencer by GlobeSt.com
Boca Raton, FL, Jan. 30, 2024 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled platform […]
Mullen Opens Dominican Republic and Caribbean Markets for Commercial EVs
Initial order is for 20 CAMPUS EV cargo vans with regular scheduled orders to follow BREA, Calif., Jan. 30, 2024 […]
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]
Sonoco Announces Agreement for the Divestiture of its Protective Solutions Packaging Business as Part of Planned Portfolio Optimization Strategy
HARTSVLLE, S.C., Jan. 30, 2024 (GLOBE NEWSWIRE) — Sonoco Products Company (“Sonoco” or the “Company”)(NYSE: SON), one of the largest global […]
Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use
Autonomix now wholly owns development and commercialization rights to its technology in all indications Re-acquisition broadens Autonomix’s development and strategic […]
